DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
V••••••• T••••••••• I••
Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Also written as: 11; 11/6/2023; 2023; 6; Equity; Inc. and
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$594,000
n/a on cost, debt pieces
Unfunded
$0
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
2 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
3
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2026 | at least $24.5M | 100c | S+145 bp | Oct 1, 2030 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| H••••••• C••••••• I••• | equity equity C••••• S•••• | n/a | $594,000 149c | |
| H••••••• C••••••• I••• | unstated lien unstated | n/a | n/a |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $0 | $0 | n/a | 0 |
| Mar 31, 2026 | 1 | $24.5M | $24.4M | 100c | 0 |
| Dec 31, 2025 | 1 | $49.0M | $48.7M | 100c | 0 |
| Sep 30, 2025 | 1 | $8.0M | $8.5M | 102c | 0 |
| Jun 30, 2025 | 1 | $8.0M | $8.5M | 102c | 0 |
| Mar 31, 2025 | 1 | $8.0M | $8.5M | 103c | 0 |
| Dec 31, 2024 | 1 | $8.0M | $8.5M | 104c | 0 |
| Sep 30, 2024 | 1 | $8.0M | $8.3M | 102c | 0 |
| Jun 30, 2024 | 1 | $8.0M | $8.2M | 101c | 0 |
| Mar 31, 2024 | 1 | $8.0M | $8.1M | 99c | 0 |
| Dec 31, 2023 | 1 | $16.0M | $16.0M | 100c | 0 |
| Sep 30, 2023 | 1 | $8.0M | $7.9M | 98c | 0 |
| Jun 30, 2023 | 1 | $2.0M | $1.9M | 96c | 0 |
| Mar 31, 2023 | 1 | $2.0M | $1.9M | 96c | 0 |
| Dec 31, 2022 | 1 | $2.0M | $1.9M | 96c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2026
- Maturity extended (observed)Dec 31, 2025
- Spread changed (observed)Dec 31, 2025
- Maturity extended (observed)Dec 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- V••••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Drug Discovery & Developmentreportedas one filer wrote it